How the body's 24-hour clock affects aging and brain health

Circadian-Regulated Aging Physiologies

NIH-funded research Columbia University Health Sciences · NIH-11326257

Researchers are looking at whether strengthening the body's daily clock can slow age-related declines that contribute to memory problems and Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11326257 on NIH RePORTER

What this research studies

The team studies how the internal 24-hour 'circadian' clock controls sleep, metabolism, and tissue-specific functions and how those rhythms break down with age. They use fruit flies and mammalian models to test time-restricted feeding schedules and other ways to restore circadian rhythms, building on preliminary fly data showing longer life and better metabolism. The project maps central (brain) and peripheral (body) clocks to find molecular targets that might be changed by drugs or lifestyle timing. Results could point to practical timing-based approaches or new therapies to help older adults maintain healthier sleep, metabolism, and brain function.

Who could benefit from this research

Good fit: Older adults with sleep or daily rhythm disturbances, people worried about memory decline, or those at increased risk for Alzheimer's would be most relevant.

Not a fit: People whose conditions come from non-circadian genetic disorders or from injuries unrelated to daily rhythms may not benefit from these approaches.

Why it matters

Potential benefit: If successful, this work could lead to timing-based lifestyle changes or new treatments that preserve sleep, metabolism, and memory in older adults, potentially lowering Alzheimer's risk.

How similar studies have performed: Time-restricted feeding and other circadian interventions have extended lifespan and improved rhythms in animal studies, but translating these findings to human Alzheimer's prevention remains largely unproven.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.